ArticleFrontiers in oncology2023

Concurrent sintilimab with sequential chemoradiotherapy for unresectable, stage III non-small cell lung cancer: a retrospective study.

Shi Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.